Eli Lilly’s stock jumps as Zepbound sales nearly triple at lower prices
Up next
Author


Eli Lilly’s stock rallies, as Zepbound sales nearly tripled, leading to record revenue and a raised full-year outlook.

You May Also Like
Paul Krugman thinks bond yields may be rising due to an ‘insanity premium’

Paul Krugman thinks bond yields may be rising due to an ‘insanity premium’

Economist Paul Krugman says a rise in 10-year yields may be driven…
A retirement expert’s best advice? Don’t retire.

A retirement expert’s best advice? Don’t retire.

Economist Alicia Munnell spoke to MarketWatch about the retirement “crisis” and her…
Quantum-computing stocks have been red hot. HSBC has just claimed a major trading breakthrough using the technology.

Quantum-computing stocks have been red hot. HSBC has just claimed a major trading breakthrough using the technology.

The banking giant says it has shown the technology improves its algorithmic…
Boeing confirms talks with Spirit AeroSystems as it aims to ‘improve quality’

Boeing confirms talks with Spirit AeroSystems as it aims to ‘improve quality’

Boeing Co. late Friday confirmed talks about buying supplier Spirit AeroSystems Holdings…